Literature DB >> 17088491

Markers of sulfadoxine-pyrimethamine-resistant Plasmodium falciparum in placenta and circulation of pregnant women.

Frank P Mockenhaupt1, George Bedu-Addo, Claudia Junge, Lena Hommerich, Teunis A Eggelte, Ulrich Bienzle.   

Abstract

Placental sequestration of Plasmodium falciparum in pregnancy may impair the usefulness of molecular markers of sulfadoxine-pyrimethamine resistance. In 300 infected, delivering women, the concordance of PCR-restriction fragment length polymorphism-derived parasite resistance alleles in matched samples from placenta and circulation was 83 to 98%. Sulfadoxine-pyrimethamine resistance typing in peripheral blood is reasonably representative of P. falciparum infecting pregnant women.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17088491      PMCID： PMC1797640          DOI： 10.1128/AAC.00856-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  12 in total

1.  Demonstration of a high level of parasite population homology by quantification of Plasmodium falciparum alleles in matched peripheral, placental, and umbilical cord blood samples.

Authors:  Sayeh Jafari-Guemouri; Nicaise Tuikue Ndam; Gwladys Bertin; Emily Renart; Sokhna Sow; Jean-Yves Le Hesran; Philippe Deloron
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

2.  Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion.

Authors:  M T Duraisingh; J Curtis; D C Warhurst
Journal:  Exp Parasitol       Date:  1998-05       Impact factor: 2.011

3.  Comparative efficacy of chloroquine and sulphadoxine--pyrimethamine in pregnant women and children: a meta-analysis.

Authors:  Gertrude C Kalanda; Jenny Hill; Francine H Verhoeff; Bernard J Brabin
Journal:  Trop Med Int Health       Date:  2006-05       Impact factor: 2.622

4.  Field evaluation of the use of an ELISA to detect chloroquine and its metabolites in blood, urine and breast-milk.

Authors:  A M Witte; H J Klever; B J Brabin; T A Eggelte; H J Van der Kaay; M P Alpers
Journal:  Trans R Soc Trop Med Hyg       Date:  1990 Jul-Aug       Impact factor: 2.184

5.  Plasmodium falciparum dihydrofolate reductase alleles and pyrimethamine use in pregnant Ghanaian women.

Authors:  F P Mockenhaupt; T A Eggelte; T Böhme; W N Thompson; U Bienzle
Journal:  Am J Trop Med Hyg       Date:  2001-07       Impact factor: 2.345

Review 6.  The burden of malaria in pregnancy in malaria-endemic areas.

Authors:  R W Steketee; B L Nahlen; M E Parise; C Menendez
Journal:  Am J Trop Med Hyg       Date:  2001 Jan-Feb       Impact factor: 2.345

7.  Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites.

Authors:  A M Nzila; E K Mberu; J Sulo; H Dayo; P A Winstanley; C H Sibley; W M Watkins
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

8.  Diagnosis of placental malaria.

Authors:  Frank P Mockenhaupt; Ulrike Ulmen; Christiane von Gaertner; George Bedu-Addo; Ulrich Bienzle
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

9.  Plasmodium falciparum: PCR detection and genotyping of isolates from peripheral, placental, and cord blood of pregnant Malawian women and their infants.

Authors:  Deborah D Kamwendo; Fraction K Dzinjalamala; Georges Snounou; Maxwell C C Kanjala; Chisale G Mhango; Malcolm E Molyneux; Stephen J Rogerson
Journal:  Trans R Soc Trop Med Hyg       Date:  2002 Mar-Apr       Impact factor: 2.184

10.  Hidden Plasmodium falciparum parasites in human infections: different genotype distribution in the peripheral circulation and in the placenta.

Authors:  Dietlind Schleiermacher; Jean-Yves Le Hesran; Jean-Louis Ndiaye; Ronald Perraut; Alioune Gaye; Odile Mercereau-Puijalon
Journal:  Infect Genet Evol       Date:  2002-12       Impact factor: 3.342
View more
  15 in total

1.  Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study.

Authors:  Steve M Taylor; Alejandro L Antonia; Ebbie Chaluluka; Victor Mwapasa; Gaoqian Feng; Malcolm E Molyneux; Feiko O ter Kuile; Steven R Meshnick; Stephen J Rogerson
Journal:  Clin Infect Dis       Date:  2012-03-22       Impact factor: 9.079

2.  Prevalence of Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine among pregnant women receiving intermittent preventive treatment for malaria in Uganda.

Authors:  Anthony K Mbonye; Josephine Birungi; Stephanie K Yanow; Sandra Shokoples; Samuel Malamba; Michael Alifrangis; Pascal Magnussen
Journal:  Antimicrob Agents Chemother       Date:  2015-06-29       Impact factor: 5.191

3.  Murine cerebral malaria development is independent of toll-like receptor signaling.

Authors:  Dieudonnée Togbe; Louis Schofield; Georges E Grau; Bruno Schnyder; Victorine Boissay; Sabine Charron; Stéphanie Rose; Bruce Beutler; Valérie F J Quesniaux; Bernhard Ryffel
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

4.  Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment.

Authors:  W E Harrington; T K Mutabingwa; A Muehlenbachs; B Sorensen; M C Bolla; M Fried; P E Duffy
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-18       Impact factor: 11.205

5.  Molecular Markers of Plasmodium falciparum Drug Resistance in Parasitemic Pregnant Women in the Middle Forest Belt of Ghana.

Authors:  Joseph Osarfo; Harry Tagbor; Pascal Magnussen; Michael Alifrangis
Journal:  Am J Trop Med Hyg       Date:  2018-03-22       Impact factor: 2.345

6.  Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya.

Authors:  Nnaemeka C Iriemenam; Monica Shah; Wangeci Gatei; Anna M van Eijk; John Ayisi; Simon Kariuki; Jodi Vanden Eng; Simon O Owino; Ashima A Lal; Yusuf O Omosun; Kephas Otieno; Meghna Desai; Feiko O ter Kuile; Bernard Nahlen; Julie Moore; Mary J Hamel; Peter Ouma; Laurence Slutsker; Ya Ping Shi
Journal:  Malar J       Date:  2012-07-04       Impact factor: 2.979

7.  Malaria risk factors in women on intermittent preventive treatment at delivery and their effects on pregnancy outcome in Sanaga-Maritime, Cameroon.

Authors:  Calvin Tonga; Helen Kuokuo Kimbi; Judith Kuoh Anchang-Kimbi; Hervé Nyabeyeu Nyabeyeu; Zacharie Bissemou Bissemou; Léopold G Lehman
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

8.  Genotype comparison of Plasmodium vivax and Plasmodium falciparum clones from pregnant and non-pregnant populations in North-west Colombia.

Authors:  Eliana M Arango; Roshini Samuel; Olga M Agudelo; Jaime Carmona-Fonseca; Amanda Maestre; Stephanie K Yanow
Journal:  Malar J       Date:  2012-11-26       Impact factor: 2.979

9.  Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy.

Authors:  Lena Hommerich; Christa von Oertzen; George Bedu-Addo; Ville Holmberg; Patrick A Acquah; Teunis A Eggelte; Ulrich Bienzle; Frank P Mockenhaupt
Journal:  Malar J       Date:  2007-11-08       Impact factor: 2.979

10.  Lack of effect of intermittent preventive treatment for malaria in pregnancy and intense drug resistance in western Uganda.

Authors:  Vera Braun; Eva Rempis; Alexandra Schnack; Sarah Decker; John Rubaihayo; Nazarius Mbona Tumwesigye; Stefanie Theuring; Gundel Harms; Priscilla Busingye; Frank P Mockenhaupt
Journal:  Malar J       Date:  2015-09-26       Impact factor: 2.979
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.